BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baimas-George M, Watson M, Sulzer J, Salibi P, Murphy KJ, Levi D, Martinie JB, Vrochides D, Baker EH, Ocuin L, Iannitti DA. Pathologic response translates to improved patient survival after locoregional treatment for hepatocellular carcinoma: the importance of minimally invasive microwave ablation. Surg Endosc 2021;35:3122-30. [PMID: 32588344 DOI: 10.1007/s00464-020-07747-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhu ZY, Yuan M, Yang PP, Xie B, Wei JZ, Qin ZQ, Qian Z, Wang ZY, Fan LF, Qian JY, Tan YL. Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score. World J Surg Oncol 2022;20:192. [PMID: 35689233 DOI: 10.1186/s12957-022-02643-w] [Reference Citation Analysis]
2 Habibollahi P, Sheth RA, Cressman ENK. Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review.Cancers (Basel). 2020;13. [PMID: 33396289 DOI: 10.3390/cancers13010104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]